BioSpace News Archive

Claudia Hardy says she’s found her life’s mission. As director of Community Health Access and Relations for the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham - the only National Cancer Institute-Designated Cancer Center in the state - she brings cancer resources and preventive care to communities in Alabama’s Black Belt like the one she grew up in.

Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on Thursday, November 30, 2023.

MindBio Therapeutics Corp. is pleased to report two of its team members have been honoured with industry leading awards.

Gain Therapeutics, Inc. today announced the pricing of an underwritten public offering of 2,213,044 shares of its common stock and warrants to purchase up to an aggregate of 1,106,522 shares of its common stock at a combined public offering price of $2.005 per share and accompanying warrant.

Syndax Pharmaceuticals (Nasdaq: SNDX) today announced that data from the pivotal trial of revumenib, the Company’s highly selective, oral menin inhibitor, will be featured in a late-breaking presentation at the 65th American Society of Hematology (ASH) Annual Meeting being held December 9-12, 2023 in San Diego, California.

Genentech today announced a multi-year strategic research collaboration with NVIDIA that couples Genentech’s artificial intelligence (AI) capabilities, extensive biological and molecular datasets, and research expertise with NVIDIA’s world-leading accelerated computing capabilities and AI to speed up drug discovery and development

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing drugs targeting the endocannabinoid system to address diseases including glaucoma and metabolic conditions

With Alzheimer’s disease expected to afflict 12.7 million Americans by 2050, researchers at Penn State University and Duke University Medical Center are advancing our understanding of the disease’s behavior in different people – making personalized, optimized treatment possible for the first time. And they’re doing it with math.

Tvardi Therapeutics, Inc. announced that the management team will present at the 35th Annual Piper Sandler Healthcare Conference on Tuesday, November 28, 2023, and will participate in one-on-one meetings with investors throughout the day,

GE HealthCare has received U.S. FDA 510 Clearance for the new version of Digital Expert Access with remote scanning, the first remote patient scan solution with 510 Clearance.